148 Participants Needed

NeuroVision Monitoring for Spinal Surgery Safety

Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Rush University Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM or conventional hospital based IONM to assess incidence of new-onset neurological injury.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is NeuroVision Monitoring for Spinal Surgery generally safe for humans?

Intraoperative neurophysiological monitoring (IONM), including NeuroVision Monitoring, is widely used during surgeries to help prevent nerve damage by monitoring nerve function in real time. It is considered a standard and safe practice in many surgical procedures, including spinal surgeries, to improve safety and outcomes.12345

How is NeuroVision Monitoring for Spinal Surgery Safety different from other treatments?

NeuroVision Monitoring, or intraoperative neurophysiological monitoring (IONM), is unique because it uses a combination of neurophysiological tests to monitor the spinal cord and nerve function during surgery, helping to prevent nerve damage by providing real-time feedback to the surgical team. This approach is particularly valuable in complex spinal surgeries, as it allows for early detection of potential issues, which can improve surgical outcomes and reduce the risk of postoperative complications.12678

What data supports the effectiveness of the treatment NeuroVision Monitoring for Spinal Surgery Safety?

Intraoperative neurophysiological monitoring (IONM) is shown to be valuable for detecting and preventing nerve damage during spine surgery, improving surgical outcomes, and serving as a safety measure. It is considered the standard of care in many places, providing a safety net to prevent or minimize nerve damage during complex spinal surgeries.12789

Are You a Good Fit for This Trial?

This trial is for patients who can consent and are having their first single or multilevel lateral spinal surgery due to conditions like myelopathy, radiculopathy, stenosis, herniated discs, degenerative disc disease, spondylosis. It's not for those with recent spinal trauma, active infections or a history of cancer.

Inclusion Criteria

Patients able to provide informed consent
I am having spine surgery for a condition like herniated disc or spinal stenosis.

Exclusion Criteria

I currently have an infection.
I have or had cancer.
I have had a spinal injury in the last 2 years.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo lateral spinal surgery with either NeuroVision® IONM or conventional hospital-based IONM

Intraoperative
1 visit (in-person)

Immediate Post-operative Monitoring

Participants are monitored for false positive and false negative events in IONM modalities

1 day

Follow-up

Participants are monitored for adverse events and new-onset neurological injury

2 months

Long-term Follow-up

Participants are assessed for incidence of new-onset neurological injury

2 years

What Are the Treatments Tested in This Trial?

Interventions

  • Hospital Based IONM
  • NeuroVision® IONM
Trial Overview The study compares two types of intraoperative neuromonitoring (IONM) during lateral spine surgery: NeuroVision® IONM and standard hospital-based IONM. The goal is to see which method better prevents new neurological injuries.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: NeuroVision® IONMExperimental Treatment1 Intervention
Group II: Conventional hospital based IONMActive Control1 Intervention

Hospital Based IONM is already approved in European Union, United States for the following indications:

🇪🇺
Approved in European Union as Intraoperative Neurophysiological Monitoring for:
🇺🇸
Approved in United States as Intraoperative Neurophysiological Monitoring for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rush University Medical Center

Lead Sponsor

Trials
448
Recruited
247,000+

Published Research Related to This Trial

In a review of 46 cases of lumbar intradural schwannoma resection, the use of intraoperative multimodal neuromonitoring (IONM) did not lead to any additional motor deficits post-surgery, indicating its safety in this context.
Although IONM did not change clinical outcomes compared to surgeries without it, it is still preferred for its ability to enhance surgeon confidence and provide important data for medicolegal situations, despite the increased costs and longer surgery times.
Intraoperative Neurophysiologic Monitoring for Lumbar Intradural Schwannomas: Does It Affect Clinical Outcome?Kahraman, S., Gocmen, S., Alpsan Gokmen, MH., et al.[2023]
Intraoperative neuromonitoring (IONM) was used in 18% of pediatric scoliosis surgeries and was associated with a higher likelihood of patients being discharged home, indicating a potential benefit in postoperative recovery.
While IONM showed a trend towards reducing neurologic complications (0.9% with IONM vs. 1.4% without), this finding was not statistically significant, suggesting further research is needed to confirm its efficacy in preventing such complications.
Influence of Intraoperative Neuromonitoring on the Outcomes of Surgeries for Pediatric Scoliosis in the United States.George, J., Das, S., Egger, AC., et al.[2020]
In a study of 26 patients undergoing spinal surgery, multimodal intraoperative neurophysiological monitoring (IONM) effectively combined methods like motor evoked potentials (MEP) and somatosensory evoked potentials (SSEP) to enhance the safety and outcomes of surgeries involving spinal cord pathologies.
The monitoring revealed significant changes in MEPs and SSEPs in some patients, helping to identify risks during surgery; however, postoperative neurological deficits occurred in 2 patients, highlighting the importance of IONM in maintaining neural integrity during complex spinal procedures.
Multimodal Intraoperative Neurophysiological Monitoring in Spinal Cord Surgery.Taskiran, E., Brandmeier, S., Ozek, E., et al.[2018]

Citations

Intraoperative Neurophysiologic Monitoring for Lumbar Intradural Schwannomas: Does It Affect Clinical Outcome? [2023]
Influence of Intraoperative Neuromonitoring on the Outcomes of Surgeries for Pediatric Scoliosis in the United States. [2020]
Multimodal Intraoperative Neurophysiological Monitoring in Spinal Cord Surgery. [2018]
Role of multimodal intraoperative neurophysiological monitoring during positioning of patient prior to cervical spine surgery. [2022]
Intraoperative neurophysiologic monitoring during spinal surgery. [2022]
Intraoperative neurophysiologic monitoring: utility and anesthetic implications. [2018]
Continuous intraoperative neuromonitoring in thyroid surgery: Safety analysis of 400 consecutive electrode probe placements with standardized procedures. [2018]
A Deep Learning Model for Automated Classification of Intraoperative Continuous EMG. [2022]
Review of the Role of Intraoperative Neurophysiological Monitoring in Spinal Surgery With a Focus on the True and False Positives and a Clinical Correlation. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security